Asymptomatic cardiovascular manifestations in diabetes mellitus: left ventricular diastolic dysfunction and silent
Jelena P Seferović-Mitrović1, Nebojsa M Lalić, Bosiljka Vujisić-Tesić
1Department of Endocrinology, Diabetes, and Metabolic Disorders, Clinical Centre of Serbia, Belgrade, Serbia. jpseferovic@yahoo.com
Insights
This study found that 17.3% of type 2 diabetes patients have asymptomatic cardiovascular complications like left ventricular diastolic dysfunction (LVDD) and silent myocardial ischemia (SMI). Early detection is key for managing diabetes-related heart issues.
Area of Science:
- Cardiology
- Diabetology
- Internal Medicine
Background:
- Cardiovascular complications in diabetes can be asymptomatic.
- Left ventricular diastolic dysfunction (LVDD) is an early metabolic lesion in diabetic patients, detectable by tissue Doppler echocardiography.
- Silent myocardial ischemia (SMI) is a common ischemic heart disease manifestation in diabetes.
Purpose of the Study:
- To determine the prevalence of LVDD and SMI in type 2 diabetes patients.
- To compare demographic, clinical, and metabolic data between patients with and without LVDD and SMI.
Main Methods:
- Investigated 104 type 2 diabetic patients with varying blood pressure levels.
- Conducted laboratory assessments, transthoracic echocardiography with tissue Doppler, and exercise stress echocardiography.
Main Results:
- LVDD was diagnosed in 11.5% and SMI in 5.8% of patients.
- Patients with LVDD used metformin less frequently compared to other groups.
- Higher HDL cholesterol and apolipoprotein A1 levels were observed in patients with LVDD.
Conclusions:
- The study identified asymptomatic cardiovascular complications in 17.3% of type 2 diabetes patients.
- Highlights the importance of screening for cardiac abnormalities in diabetic individuals.
Introduction:
Several cardiovascular manifestations in patients with diabetes may be asymptomatic. Left ventricular diastolic dysfunction (LVDD) is considered to be the earliest metabolic myocardial lesion in these patients, and can be diagnosed with tissue Doppler echocardiography. Silent myocardial ischemia (SMI) is a characteristic and frequently described form of ischemic heart disease in patients with diabetes. Objective The aim of the study was to assess the prevalence of LVDD and SMI in patients with type 2 diabetes, as well as to compare demographic, clinical, and metabolic data among defined groups (patients with LVDD, patients with SMI and patients with type 2 diabetes, without LVDD and SMI).
Methods:
We investigated 104 type 2 diabetic patients (mean age 55.4 +/- 9.1 years, 64.4% males) with normal blood pressure, prehypertension and arterial hypertension stage I. Study design included basic laboratory assessment and cardiological workup (transthoracic echocardiography and tissue Doppler, as well as the exercise stress echocardiography).
Results:
LVDD was diagnosed in twelve patients (11.5%), while SMI was revealed in six patients (5.8%). Less patients with LVDD were using metformin, in comparison to other two groups (chi2 =12.152; p=0.002). Values of HDL cholesterol (F=4.515; p=0.013) and apolipoprotein A1 (F=5.128; p= 0.008) were significantly higher in patients with LVDD.
Conclusion:
The study confirmed asymptomatic cardiovascular complications in 17.3% patients with type 2 diabetes.
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Hypertension III: Clinical Manifestations and Diagnostic Studies

